The National Institute on Aging (NIA), in conjunction with other National Institutes of Health departments, is offering this grant as a pivotal part of the Alzheimer’s Disease Prevention Initiative. This grant is specifically designed to quicken the pace for translating foundational basic science findings into tangible clinical trials. Its central purpose is to evaluate novel treatment and prevention strategies for Alzheimer’s disease. Qualified investigators are encouraged to submit applications for pilot clinical trials employing either pharmacologic or behavioral interventions. This funding opportunity is for projects focusing on the prevention and effective treatment of cognitive and behavioral symptoms linked to mild cognitive impairment, diagnosed Alzheimer’s disease, and general age-related cognitive decline, advancing critical research in this field.
Opportunity ID: 64834
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-11-100 |
Funding Opportunity Title: | Alzheimer’s Disease Pilot Clinical Trials (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.361 — Nursing Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jan 14, 2011 |
Last Updated Date: | – |
Original Closing Date for Applications: | Jan 07, 2014 |
Current Closing Date for Applications: | Jan 07, 2014 |
Archive Date: | Feb 07, 2014 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities State governments County governments Private institutions of higher education Special district governments Native American tribal governments (Federally recognized) Independent school districts |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | In 1999, at the direction of Congress, the National Institute on Aging (NIA), in conjunction with the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Mental Health (NIMH), and the National Institute of Nursing Research (NINR) embarked on the Alzheimer’s Disease (AD) Prevention Initiative, which encompasses a number of interrelated efforts including basic, epidemiological, behavioral, and clinical research. An important part of the AD Prevention Initiative is to quicken the pace for translating basic science findings into clinical trials to evaluate treatment and prevention strategies. This funding opportunity announcement (FOA) focuses on AD pilot clinical trials while other FOAs are targeted to AD drug discovery and development.
In this FOA the National Institute on Aging (NIA) invites qualified investigators to submit research grant applications for pilot clinical trials using pharmacologic and/or behavioral interventions directed toward the prevention and treatment of the cognitive and behavioral symptoms of mild cognitive impairment (MCI), Alzheimer’s disease (AD), and age-related cognitive decline. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-11-100.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.361 | ADOBE-FORMS-B1 | ADOBE-FORMS-B1 | PKG00027410 | Jan 18, 2011 | Sep 24, 2013 | View |
93.361 | FORMS-C | Use for due dates after 9/24/2013. | PKG00180572 | Sep 08, 2013 | Jan 07, 2014 | View |
Package 1
Mandatory forms
64834 RR_SF424_1_2-1.2.pdf
64834 RR_OtherProjectInfo_1_3-1.3.pdf
64834 RR_KeyPersonExpanded_1_2-1.2.pdf
64834 PerformanceSite_1_4-1.4.pdf
64834 PHS398_ResearchPlan_1_3-1.3.pdf
64834 PHS398_CoverPageSupplement_1_4-1.4.pdf
64834 PHS398_Checklist_1_3-1.3.pdf
Optional forms
64834 RR_Budget-1.1.pdf
64834 RR_SubawardBudget-1.2.pdf
64834 PHS_CoverLetter_1_2-1.2.pdf
64834 PHS398_ModularBudget-1.1.pdf
Package 2
Mandatory forms
64834 RR_SF424_2_0-2.0.pdf
64834 PHS398_ResearchPlan_2_0-2.0.pdf
64834 PHS398_CoverPageSupplement_2_0-2.0.pdf
64834 RR_KeyPersonExpanded_2_0-2.0.pdf
64834 RR_OtherProjectInfo_1_3-1.3.pdf
64834 PerformanceSite_2_0-2.0.pdf
Optional forms
64834 RR_SubawardBudget30_1_3-1.3.pdf
64834 PlannedReport-1.0.pdf
64834 PHS398_CumulativeInclusionReport-1.0.pdf
64834 PHS398_ModularBudget_1_2-1.2.pdf
64834 RR_Budget_1_3-1.3.pdf